| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |